HEATHER MCLENNAN: Open Payments
NPI 1417258740 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$689 in 29 payments from 11 companies in 2025. Trend: 2023 $447 · 2024 $638 · 2025 $689
Food & beverage: $689
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma Global Development | 1 | $150 |
| Astellas Pharma US Inc | 6 | $127 |
| Biogen, Inc. | 4 | $101 |
| ABBVIE INC. | 3 | $79 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $78 |
| MILLICENT US INC | 4 | $60 |
| Exeltis, USA Inc. | 2 | $27 |
| Radius Health, Inc. | 1 | $19 |
| Hologic Sales and Service, LLC | 1 | $17 |
| SHIELD THERAPEUTICS INC | 1 | $16 |
Products named: Veozah, ZURZUVAE, BOTOX, VRAYLAR, INTRAROSA, FEMLYV, SLYND, Tymlos.
Industry payments across KY — which companies pay providers there.
